Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirotoshi Watanabe

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Circulation. Cardiovascular Interventions|August 1, 2022
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total CohortYuki Obayashi, Hirotoshi Watanabe, Takeshi Morimoto, et al.
JAMA Cardiology|March 20, 2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-AnalysisMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Circulation|October 27, 2024
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary InterventionFelice Gragnano, David van Klaveren, Dik Heg, et al.
Circulation. Cardiovascular Interventions|May 16, 2023
Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary InterventionKo Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Journal of the American Heart Association|February 5, 2019
Prognostic Impact of Aortic Valve Area in Conservatively Managed Patients With Asymptomatic Severe Aortic Stenosis With Preserved Ejection FractionNorio Kanamori, Tomohiko Taniguchi, Takeshi Morimoto, et al.
BMJ Open|April 1, 2021
Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort studyYasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation. Population Health and Outcomes|February 16, 2026
Changes in Demographics, Initial Treatment Strategies, and Clinical Outcomes of Severe Aortic Stenosis in the Pre- and Post-TAVR Era in JapanYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 21, 2022
Rationale, Design, and Baseline Characteristics of the CURRENT AS Registry-2Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 18, 2024
Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and HypertensionKo Yamamoto, Yasuaki Takeji, Tomohiko Taniguchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 16, 2021
Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan - From the CREDO-Kyoto Registry Cohort-2 and Cohort-3Masahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Circulation. Cardiovascular Interventions|August 1, 2022
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total CohortYuki Obayashi, Hirotoshi Watanabe, Takeshi Morimoto, et al.
JAMA Cardiology|March 20, 2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-AnalysisMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Circulation|October 27, 2024
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary InterventionFelice Gragnano, David van Klaveren, Dik Heg, et al.
Circulation. Cardiovascular Interventions|May 16, 2023
Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary InterventionKo Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Journal of the American Heart Association|February 5, 2019
Prognostic Impact of Aortic Valve Area in Conservatively Managed Patients With Asymptomatic Severe Aortic Stenosis With Preserved Ejection FractionNorio Kanamori, Tomohiko Taniguchi, Takeshi Morimoto, et al.
BMJ Open|April 1, 2021
Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort studyYasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation. Population Health and Outcomes|February 16, 2026
Changes in Demographics, Initial Treatment Strategies, and Clinical Outcomes of Severe Aortic Stenosis in the Pre- and Post-TAVR Era in JapanYasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 21, 2022
Rationale, Design, and Baseline Characteristics of the CURRENT AS Registry-2Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 18, 2024
Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and HypertensionKo Yamamoto, Yasuaki Takeji, Tomohiko Taniguchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 16, 2021
Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan - From the CREDO-Kyoto Registry Cohort-2 and Cohort-3Masahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, et al.
Pageof 11